Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Smoking-related health beliefs and smoking behavior in the National Lung Screening Trial.

Kaufman AR, Dwyer LA, Land SR, Klein WMP, Park ER.

Addict Behav. 2018 Sep;84:27-32. doi: 10.1016/j.addbeh.2018.03.015. Epub 2018 Mar 14.

PMID:
29605757
2.

Cancer burden attributable to cigarette smoking among HIV-infected people in North America.

Altekruse SF, Shiels MS, Modur SP, Land SR, Crothers KA, Kitahata MM, Thorne JE, Mathews WC, Fernández-Santos DM, Mayor AM, Gill JM, Horberg MA, Brooks JT, Moore RD, Silverberg MJ, Althoff KN, Engels EA.

AIDS. 2018 Feb 20;32(4):513-521. doi: 10.1097/QAD.0000000000001721.

PMID:
29239891
3.

Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.

Kathuria H, Detterbeck FC, Fathi JT, Fennig K, Gould MK, Jolicoeur DG, Land SR, Massetti GM, Mazzone PJ, Silvestri GA, Slatore CG, Smith RA, Vachani A, Zeliadt SB, Wiener RS; ATS Assembly on Thoracic Oncology.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1202-1212. doi: 10.1164/rccm.201709-1858ST.

PMID:
29090963
4.

Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01.

Kunitake H, Russell MM, Zheng P, Yothers G, Land SR, Petersen L, Fehrenbacher L, Giguere JK, Wickerham DL, Ko CY, Ganz PA.

J Cancer Surviv. 2017 Feb;11(1):111-118. doi: 10.1007/s11764-016-0567-y. Epub 2016 Aug 25.

5.

Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research.

Land SR, Warren GW, Crafts JL, Hatsukami DK, Ostroff JS, Willis GB, Chollette VY, Mitchell SA, Folz JN, Gulley JL, Szabo E, Brandon TH, Duffy SA, Toll BA.

Cancer. 2016 Jun 1;122(11):1728-34. doi: 10.1002/cncr.29964. Epub 2016 Mar 28.

6.

Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research.

Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP, Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC, Warren GW.

Clin Cancer Res. 2016 Apr 15;22(8):1907-13. doi: 10.1158/1078-0432.CCR-16-0104. Epub 2016 Feb 17.

7.

Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.

Land SR, Walcott FL, Liu Q, Wickerham DL, Costantino JP, Ganz PA.

J Natl Cancer Inst. 2015 Nov 27;108(4). pii: djv365. doi: 10.1093/jnci/djv365. Print 2016 Apr.

8.

Cancer screening and diagnosis: opportunities for smoking cessation intervention.

Land SR, Marcus PM.

J Clin Oncol. 2015 May 20;33(15):1631-2. doi: 10.1200/JCO.2015.61.2077. Epub 2015 Apr 20. No abstract available.

PMID:
25897157
9.

Comparison of media literacy and usual education to prevent tobacco use: a cluster-randomized trial.

Primack BA, Douglas EL, Land SR, Miller E, Fine MJ.

J Sch Health. 2014 Feb;84(2):106-15. doi: 10.1111/josh.12130.

10.

Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.

Land SR, Liu Q, Wickerham DL, Costantino JP, Ganz PA.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):823-32. doi: 10.1158/1055-9965.EPI-13-1105-T. Epub 2014 Feb 25.

11.

Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.

Song JY, Siegfried JM, Diergaarde B, Land SR, Bowser R, Stabile LP, Dacic S, Dhir R, Nukui T, Romkes M, Weissfeld JL.

Cancer Epidemiol. 2013 Aug;37(4):518-22. doi: 10.1016/j.canep.2013.03.020. Epub 2013 Apr 23.

12.

CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer.

Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL.

Subst Use Misuse. 2013 May;48(7):490-4. doi: 10.3109/10826084.2013.778280. Epub 2013 Mar 25.

13.

Associations of mental health problems with waterpipe tobacco and cigarette smoking among college students.

Primack BA, Land SR, Fan J, Kim KH, Rosen D.

Subst Use Misuse. 2013 Feb;48(3):211-9. doi: 10.3109/10826084.2012.750363. Epub 2013 Jan 10.

14.

Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.

Kopec JA, Colangelo LH, Land SR, Julian TB, Brown AM, Anderson SJ, Krag DN, Ashikaga T, Costatino JP, Wolmark N, Ganz PA.

J Support Oncol. 2013 Mar;11(1):22-30.

15.

Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.

Stabile LP, Rothstein ME, Cunningham DE, Land SR, Dacic S, Keohavong P, Siegfried JM.

Carcinogenesis. 2012 Nov;33(11):2181-9. doi: 10.1093/carcin/bgs260. Epub 2012 Aug 2. Erratum in: Carcinogenesis. 2013 Jun;34(6):1411.

16.

Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01.

Kidwell KM, Yothers G, Ganz PA, Land SR, Ko CY, Cecchini RS, Kopec JA, Wolmark N.

Cancer. 2012 Nov 15;118(22):5614-22. doi: 10.1002/cncr.27593. Epub 2012 May 8.

17.

Methodologic barriers to addressing critical questions about tobacco and cancer prognosis.

Land SR.

J Clin Oncol. 2012 Jun 10;30(17):2030-2. doi: 10.1200/JCO.2012.41.7402. Epub 2012 May 7. No abstract available.

PMID:
22564998
18.

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

Allred DC, Anderson SJ, Paik S, Wickerham DL, Nagtegaal ID, Swain SM, Mamounas EP, Julian TB, Geyer CE Jr, Costantino JP, Land SR, Wolmark N.

J Clin Oncol. 2012 Apr 20;30(12):1268-73. doi: 10.1200/JCO.2010.34.0141. Epub 2012 Mar 5.

19.

Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N.

Cancer Prev Res (Phila). 2012 Apr;5(4):583-92. doi: 10.1158/1940-6207.CAPR-11-0482. Epub 2012 Feb 7.

20.

Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.

Land SR, Cronin WM, Wickerham DL, Costantino JP, Christian NJ, Klein WM, Ganz PA.

Cancer Prev Res (Phila). 2011 Sep;4(9):1393-400. doi: 10.1158/1940-6207.CAPR-11-0172. Epub 2011 Aug 23.

Supplemental Content

Support Center